GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 2cureX AB (OSTO:2CUREX) » Definitions » Additional Paid-In Capital

2cureX AB (OSTO:2CUREX) Additional Paid-In Capital : kr111.86 Mil(As of Sep. 2023)


View and export this data going back to 2017. Start your Free Trial

What is 2cureX AB Additional Paid-In Capital?


2cureX AB's quarterly additional paid-in capital increased from Mar. 2023 (kr107.66 Mil) to Jun. 2023 (kr111.86 Mil) but then stayed the same from Jun. 2023 (kr111.86 Mil) to Sep. 2023 (kr111.86 Mil).

2cureX AB's annual additional paid-in capital increased from Dec. 2020 (kr75.39 Mil) to Dec. 2021 (kr106.61 Mil) and increased from Dec. 2021 (kr106.61 Mil) to Dec. 2022 (kr107.66 Mil).

2cureX AB Additional Paid-In Capital Historical Data

The historical data trend for 2cureX AB's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

2cureX AB Additional Paid-In Capital Chart

2cureX AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Additional Paid-In Capital
Get a 7-Day Free Trial 16.39 38.02 75.39 106.61 107.66

2cureX AB Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 107.66 107.66 107.66 111.86 111.86

2cureX AB Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

2cureX AB Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of 2cureX AB's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

2cureX AB (OSTO:2CUREX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 2cureX AB (OSTO:2CUREX) » Definitions » Additional Paid-In Capital
Comparable Companies
OSTO:LPGO XSAT:CHOSA OSTO:SCOL OSTO:EXPRS2 OSTO:COMBI XSAT:ABERA NGM:COEGIN XSAT:APTA XSAT:DBP B OSTO:ONCOZ OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
2QE:Germany
Address
Fruebjergvej 3, Copenhagen, DNK, DK-2100
Website
https://www.2curex.com
2cureX AB is a biotech company. The company is engaged in improving treatment efficiency, mainly for cancer patients. It is involved in developing a product, namely IndiTreat, which is a technology for the treatment of colorectal, ovarian, and pancreatic cancers. The company's sub-products include IndiTreat Test, IndiTreat clinical programs, and IndiTreat Therapy Design.

2cureX AB (OSTO:2CUREX) Headlines

No Headlines